Testing for Helicobacter pylori in primary care: Trouble in store?

Journal of Epidemiology and Community Health

Volumn 52, Issue 5, 1998, Pages 305-309

  Foy, R ^a   Parry, J M ^a   Murray, L ^b   Woodman, C B J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DYSPEPSIA; ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIMARY MEDICAL CARE; STOMACH CANCER;

EID: 0031745105     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.52.5.305     Document Type: Article

References (78)

1. Song F, Maynard A. Functional dyspepsia: a review of scientific and policy issues. Discussion paper 119. York: Centre for Health Economics, University of York, 1994.
2. Ryder SD, O'Reilly S, Miller RJ, et al. Long term acid suppressing treatment in general practice. BMJ 1994;308:827-30.
3. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ 1989;298:30-2.
4. McCormick A, Fleming D, Charlton J. Morbidity statistics from general Practice. Fourth National Study 1991-92. London: Office of Population Censuses and Surveys, 1995.
5. Holdstock G, Harman M, Machin D, et al. Prospective testing of a scoring system designed to improve case selection for upper gastrointestinal investigation. Gastroenterology 1986;90:1164-9.
6. Davenport PM, Morgan AG, Darnborough A. Can preliminary screening of dyspeptic patients allow more effective use of investigational techniques? BMJ 1985;290:217-19.
7. Talley NJ, Weaver AL, Tesmer DL, et al. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993;105: 1378-86.
8. Mansi C, Savarino V, Sandro Mela G, et al. Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. Am J Gastroenterol 1993;88:1011-15.
9. Marshall BJ. Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet 1983;i:1273-5.
10. Warren JR. Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet 1983;i:1273.
11. Delaney BC. Role of Helicobacter pylori in gastrointestinal disease: implications for primary care of a revolution in management of dyspepsia. Br J Gen Pract 1995;45:489-94.
12. Sander JO, Veldhuyzen van Zanten, Sherman PM. Indications for treatment of Helicobacter pylori infection: a systematic overview. Can Med Assoc J 1994;150:189-98.
13. NIH Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
14. Moore RA. Helicobacter pylori and peptic ulcer. A systematic review of effectiveness and an overview of the economic benefits of implementing what is known to be effective. Oxford: Health Technology Evaluation Association/Pain Relief Research Unit, 1995.
15. British Society of Gastroenterology. Dyspepsia management guidelines. London: BSG Guidelines in Gastroenterology, 1996.
16. European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41: 8-13.
17. Williams B, Luckas M, Ellingham JHM, et al. Do young patients with dyspepsia need investigation? Lancet 1988;ii: 1349-51.
18. Gear MWL, Barnes RJ. Endoscopic studies of dyspepsia in a general practice. BMJ 1980;280:1136-7.
19. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89:116-28.
20. Crabtree JE, Shallcross TM, Heatley RV, et al. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathol 1991;11:326-8.
21. Lin SK, Lambert JR, Schembri M, et al. A comparison of diagnostic tests to determine Helicobacter pylori infection. J Gastroenterol Hepatol 1992;7:203-9.
22. Talley NJ, Kost L, Haddad A, et al. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol 1992;30:3146-50.
23. Provonost AD, Rose SL, Pawlak JW, et al. Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results. J Clin Microbiol 1994;32:46-50.
24. Moayyedi P, Carter AM, Catto A, et al. Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ 1997;314:119.
25. Borody TJ, Andrews P, Shortis NP. Evaluation of whole blood antibody kit to detect active Helicobacter pylori infection. Am J Gastroenterol 1996;91:2509-12.
26. Duggan A, Logan R, Knifton A, et al. Accuracy of near-patient blood tests for Helicobacter pylori. [Letter]. Lancet 1996;348:617.
27. Moayyedi P, Axon ATR. Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. [Letter]. BMJ 1997;314:1690-1.
28. Stone MA, Mayberry JF, Wicks ACB, et al. The Helisal test - an assessment of readability and diagnostic accuracy. Gut 1996;39 (suppl 2):A110.
29. Cutler A, Schubert A, Schubert T. Role of Helicobacter pylori serology in evaluating treatment success. Dig Dis Sci 1993;38:2262-6.
30. Sobala GM, Crabtree JE, Pentith JA, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991; 338:94-6.
31. Morgan AG, Crabtree JE, Heatley RV, et al. Role of Helicobacter pylori serology in the initial assessment of patients with dyspepsia. [Abstract]. Gut 1991;32:T98.
32. Mendall MA, Goggin PM, Marrero JM, et al. Role of Helicobacter pylori serology in screening prior to endoscopy. Eur J Gastroenterol Hepatol 1992;4:713-17.
33. Collins JAS, Bamford KB, Sloan JM, et al. Screening for Helicobacter pylori antibody could reduce endoscopic workload in young dyspeptic patients. Eur J Gastroenterol Hepatol 1992;4:991-3.
34. Patel P, Mendall MA, Khulusi S, et al. Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. Lancet 1994;344:511-12.
35. Tham TC, McLaughlin N, Hughes DF, et al. Possible role of Helicobacter pylori serology in reducing endoscopy workload. Postgrad Med J 1994;70:809-12.
36. Mendall MA, Jazrawi RP, Marrero JM, et al. Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut 1995;36:330-3.
37. Patel P, Khulusi S, Mendall M, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995;346:1315-18.
38. Briggs AH, Sculpher MJ, Logan RPH, et al. Cost effectiveness of screening for and eradication of H pylori in management of dyspeptic patients under 45 years of age. BMJ 1996;312:1321-5.
39. Jones R. What happens to patients with non-ulcer dyspepsia after endoscopy? Practitioner 1988;232:75-8.
40. Hansen JM, Bytzer P, Bondesen S, et al. Efficacy and outcome of an open access endoscopy service. Dan Med Bull 1991;38:288-90.
41. Bytzer P, Moller Hansen J, et al. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994;343:811-16.
42. Kay L, Jorgensen T. Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol 1994;29:1-6.
43. Bernersen B, Johnsen R, Bostad L, et al. Is Helicobacter pylori the cause of dyspepsia? BMJ 1992;304:1276-9.
44. Hobbs FDR, Broughton PMG, Kenkre JE, et al. Comparison of the use of four desktop analysers in six urban general practices. Br J Gen Prac 1992;42:317-321.
45. Rink E, Hilton S, Szczepura A, et al. Impact of introducing near patient testing for standard investigations in general practice. BMJ 1993;307:775-8.
46. Cottrill M. Who should get H pylori eradication therapy? Prescriber 1994;19 Nov:61-2.
47. Phillips C, Moore A. Implementing evidence-based medical interventions: the cost-effectiveness of Helicobacter pylori diagnosis and eradication. British Journal of Medical Economics 1996;10:47-57.
48. Axon ATR. Chronic dyspepsia: who needs endoscopy? Gastroenterology 1997;112:1376-80.
49. Fendrick M, Chernew ME, Hirth RA, et al. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995;123:260-8.
50. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996;110:72-83.
51. Vaira D, Miglioli M, Mule P, et al. Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut 1994;35: 309-12.
52. Heikkinen M, Pikkarainen P, Takala J, et al. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995;30:519-23.
53. Walt RP. Metronidazole-resistant H pylori - of questionable clinical importance. Lancet 1996;348:489-90.
54. Hosking SW, Ling TK, Chung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994;343:508-10.
55. de Boer W, Driessen W, Jansz A, et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995;345:817-20.
56. Goddard AF, Logan RPH, Lawes S, et al. Metronidazole or tinidazole with omeprazole and clarithromycin for the eradication of H pylori. [Abstract]. Gut 1996;38 (suppl 1):W49.
57. IARC Monographs in the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon: International Agency for Research in Cancer, 1994: 61.
58. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991;302:1302-5.
59. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
60. Nomura A, Stemmermann GN, Chyou P-H, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325: 1132-6.
61. Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62.
62. Forman D, Webb P, Parsonnet J. H pylori and gastric cancer. Lancet 1994;343:243-4.
63. Webb PM, Forman D. Helicobacter pylori as a risk factor for cancer. Ballieres Clin Gastroenterol 1995;9:563-82.
64. Whincup PH, Mendall MA, Perry IJ, et al. Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle aged men. Heart 1995;75: 568-72.
65. Rathbone B, Martin D, Stephens J, et al. Helicobacter pylori seropositivity in subjects with acute myocardial infarction. Heart 1996;76:308-11.
66. Axon A, Forman D. Helicobacter gastroduodenitis: a serious infectious disease. BMJ 1997;314:1430.
67. Barnes RJ, Uff JS, Dent JC, et al. Long-term follow up of patients with gastritis associated with Helicobacter pylori infection. Br J Gen Pract 1991;41:286-8.
68. Marteau TM. The psychological costs of screening. BMJ 1989;299:527.
69. Cockburn J, Staples M, Hurley SF, et al. Psychological consequences of screening mammography. J Med Screen 1994; 1:7-12.
70. Bull AR, Campbell MJ. Assessment of the psychological impact of a breast screening programme. Br J Radiol 1991; 64:510-15.
71. Haynes RB, Sackett DL, Taylor DW, et al. Changes in absenteeism and psychosocial function due to hypertension screening and therapy among working men. N Engl J Med 1978;299:741-4.
72. Calman KC. Cancer: science and society and the communication of risk. BMJ 1996;313:799-802.
73. Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989;39:495-8.
74. Parry J, Foy R, Woodman CBJ. What do general practitioners tell patients prior to testing for H pylori? Br J Gen Pract 1997;47:311-312.
75. Babbs C (on behalf of the H pylori Review Group). H pylori-associated gastroduodenal disease: survey of British Physicians' views. [Abstract]. Gut (suppl 1) 1995;37:A87.
76. Logan RPH, Aldous JC, Ramsay M, et al. Helicobacter pylori, dyspepsia and peptic ulcer: perspectives and practice from primary care. [Abstract]. Gut (suppl 1) 1995;37:A88.
77. Rubin G, Stevens R. Laboratory tests for Helicobacter pylori should become more widely available. [Letter]. BMJ 1996;313:172-3.
78. Davey Smith G, Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs? BMJ 1992;304: 431-4.